Volume range 1-5 ml. Designed for use with large laboratory vessels.
300 L, Bulk Recommended for 250 and 300 L pipettes. Can also be used with 20, 25, 50, 100 and 200 L pipette
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
...easy way to order tips. Each box contains 1000 tip...ains 200 tips (4 bags of 50 tips). Also available ...s per pack. Bulk Packs are sealed with a tamper-pr...ess to Gilsons Diamond Tips. Bulk Packs are closed...
Medicine Products:(Date:11/21/2008)...ov. 21 New research at ...smokeless, spitless tobacco product aimed at young...ound that RJ Reynolds, Camel Snus - touted as a so...ins surprisingly high levels of nicotine. , ,...her snuff products," said Bruce Adkins of the stat...
(Date:11/21/2008)..., Nov. 21 Today, prescri...vention in treating 88 percent of patients sufferi...s treated for a chronic condition account for 96 p...rcent of all medical costs. A proprietary new pha...alth Solutions, Inc. (NYSE: MHS ) significantly ...
(Date:11/21/2008)...ewswire/ -- In a statewide survey, 33 physicians c... Surgery at Presbyterian Hospital of Dallas were h...ng of " Super Doctors ." , , Each year, the...ssional Media, Inc. to survey more than 38,000 med...k, "If you needed medical care, which doctor would...
(Date:11/21/2008)...cco use is more prevalent and smoking cessation le...eractivity Disorder (A.D.H.D.) In a study of smok...oms, those who exhibited elevated hyperactivity an... lower quit rates after 8 weeks than those with in...H.D. symptoms. The study, now available online in...
Breaking Medicine News(10 mins):Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2(Date:11/19/2008)...ieve statistical significance , , ISELIN, N...rporation (Nasdaq: PARS ) today announced result...NanoEmulsion (NE) drug delivery technology formula...The multi-center, randomized, double-blinded, plac...cacy of the Company,s 3% Diclofenac Diethanolamine...
(Date:11/19/2008)...wire/ -- Isogen, a contract development and,manuf...nnounced the first,phase launch of its contract f...ically address the process, facility and capacity ...highly-niched, low-volume clinical and,early-stag... Companies can invest over $100 million and fou...
(Date:11/18/2008)... to learn more, make a donation or send a Christm...Newswire-USNewswire/ -- Millions will receive Chri...e American Lung Association. These decorative holi...tion dating back to 1907 when the Lung Association... "Most Americans alive today have no vivid memorie...
(Date:11/18/2008)...008 Faces of Influenza survey underscores that mot...nza; Mother and Gold Medalist Kristi Yamaguchi joi...ewswire/ -- While 78 percent of mothers in the Uni...ally life-threatening disease that can strike anyo... get vaccinated this season, according to a new su...
Breaking Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Isogen Launches Major New Facility to Address Global Biopharma Demand 2American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6West Nile virus spread through nerve cells linked to serious complication 881 1West Nile virus spread through nerve cells linked to serious complication 881 2West Nile virus spread through nerve cells linked to serious complication 881 3Reflux Can Precipitate Chest Pain Cough 4063 1Reflux Can Precipitate Chest Pain Cough 4063 2Alarming MRSA Infection Rates Underscore Need for Public Reporting of Hospital Acquired Infections 4060 1Alarming MRSA Infection Rates Underscore Need for Public Reporting of Hospital Acquired Infections 4060 2Alarming MRSA Infection Rates Underscore Need for Public Reporting of Hospital Acquired Infections 4060 3Body Image Has Little Influence on Desire for Plastic Surgery ASPS Study Reveals 4057 1Body Image Has Little Influence on Desire for Plastic Surgery ASPS Study Reveals 4057 2Body Image Has Little Influence on Desire for Plastic Surgery ASPS Study Reveals 4057 3...luable Patients Show Stabilized Disease; Biomarker...otential for,Patient Stratification --, GERMANTOWN...lon,Pharmaceuticals, Inc. , today announced contin...y of AVN944, for the treatment of,hematologic mali...im data indicate AVN944 is well tolerated, has dos...
...-(BUSINESS WIRE)--Jun 20, 2007 - Neoprobe Corporat...ative oncology and,cardiovascular surgical and dia...nary results from a multicenter Phase 2 clinical,s... (Technetium,Tc99m DTPA-mannosyl-dextran). Lymphos...eing developed for use with handheld,gamma detecti...
Other Medicine Technology:Avalon Pharmaceuticals Announces Positive Interim Results For,AVN944 Phase I Trial 2Avalon Pharmaceuticals Announces Positive Interim Results For,AVN944 Phase I Trial 3Avalon Pharmaceuticals Announces Positive Interim Results For,AVN944 Phase I Trial 4Avalon Pharmaceuticals Announces Positive Interim Results For,AVN944 Phase I Trial 5Avalon Pharmaceuticals Announces Positive Interim Results For,AVN944 Phase I Trial 6Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint 2Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint 3